跳转至内容
Merck

SMB01325

Sigma-Aldrich

阿苯达唑亚砜

≥97% (HPLC)

别名:

[5-(丙烷-1-亚磺酰基)-1H-苯并咪唑-2-基]-氨基甲酸甲酯, 氧阿苯达唑, 阿苯达唑亚砜

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C12H15N3O3S
CAS号:
分子量:
281.33
Beilstein:
677664
MDL號碼:
分類程式碼代碼:
12352119
NACRES:
NA.77

描述

Modulation and Signaling

品質等級

化驗

≥97% (HPLC)

形狀

solid

顏色

white to beige

適合性

HPTLC

儲存溫度

2-8°C

SMILES 字串

CCCS(=O)c1ccc2[nH]c(NC(=O)OC)nc2c1

InChI

1S/C12H15N3O3S/c1-3-6-19(17)8-4-5-9-10(7-8)14-11(13-9)15-12(16)18-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)

InChI 密鑰

VXTGHWHFYNYFFV-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

Albendazole sulfoxide is a blood-brain barrier main metabolite of anti-parasitic agent albendazole that acts as a antihelminthic. It binds to colchicine binding site of β-tubulin and prevents polymerization. Albendazole sulfoxide exhibits greater affinity to parasitic β-tubulin than to mammalian.

應用

Metabolomics research

生化/生理作用

罗苯达唑是阿苯达唑的关键代谢产物,并作为驱虫药。研究表明,它可能通过使细胞周期停滞在 G2/M 期而诱导人癌细胞 HT-29 凋亡。

其他說明

For additional information on our range of Biochemicals, please complete this form.

訊號詞

Warning

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - Skin Sens. 1 - STOT RE 2 Oral

標靶器官

Adrenal gland,spleen,male reproductive organs,Blood

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lidia Radko et al.
Journal of veterinary research, 61(3), 313-319 (2018-07-07)
Albendazole is used to treat endoparasitic diseases in animals and humans. After oral administration, it is quickly oxidised into its pharmacologically active metabolite albendazole sulfoxide and then to sulfone. However, it is not clear which compound is responsible for toxic
Maximo Pettarin et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 155, 105552-105552 (2020-09-17)
The aim of this study was to use a combined in vitro-in silico approach to develop a physiologically based pharmacokinetic model (PBPK) that predicts the bioavailability of albendazole (ABZ), a BCS class II/IV lipophilic weak base, and simulates its main

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门